Nana Muazin

The New Frontier of Addiction: WHO Sounds Alarm as Global Youth Nicotine Consumption Escalates

• Global Breast Cancer Awareness

The New Frontier of Addiction: WHO Sounds Alarm as Global Youth Nicotine Consumption Escalates

Nana Muazin July 26, 2026

GENEVA – As the global community prepares to observe World No Tobacco Day on May 31, the...

Read More Read more about The New Frontier of Addiction: WHO Sounds Alarm as Global Youth Nicotine Consumption Escalates

The Dual-Coverage Challenge: Analyzing the Financial and Clinical Realities of Medicare-Medicaid Enrollees

• Breast Cancer Legislation and Policy

The Dual-Coverage Challenge: Analyzing the Financial and Clinical Realities of Medicare-Medicaid Enrollees

Nana Muazin July 26, 2026

Introduction: The Complexity of Dual Eligibility In the intricate landscape of the American healthcare system, approximately 12...

Read More Read more about The Dual-Coverage Challenge: Analyzing the Financial and Clinical Realities of Medicare-Medicaid Enrollees

Scaling the Future: Maja Herold Pedersen and the Digital Transformation of FUJIFILM Biotechnologies

• Chemotherapy and Targeted Therapy

Scaling the Future: Maja Herold Pedersen and the Digital Transformation of FUJIFILM Biotechnologies

Nana Muazin July 25, 2026

In the high-stakes world of biopharmaceutical manufacturing, the transition from clinical-scale development to commercial-grade production is often...

Read More Read more about Scaling the Future: Maja Herold Pedersen and the Digital Transformation of FUJIFILM Biotechnologies

A New Frontier in Global Health: Landmark PARTNERS Trial Launches to Combat Bundibugyo Virus in the DRC

• Breast Cancer Prevention and Lifestyle

A New Frontier in Global Health: Landmark PARTNERS Trial Launches to Combat Bundibugyo Virus in the DRC

Nana Muazin July 24, 2026

In a decisive move to curb the mortality rates associated with the Bundibugyo virus (BVD), a sophisticated...

Read More Read more about A New Frontier in Global Health: Landmark PARTNERS Trial Launches to Combat Bundibugyo Virus in the DRC

Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

• Medical Research and Clinical Trials

Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

Nana Muazin July 24, 2026

San Francisco, CA – July 23, 2026 – Arrowhead Pharmaceuticals has announced groundbreaking top-line results from its...

Read More Read more about Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

Post-COVID Surgical Risks: New Study Links History of Infection to Elevated VTE Complications in Panniculectomy Patients

• Breast Cancer Surgery and Reconstruction

Post-COVID Surgical Risks: New Study Links History of Infection to Elevated VTE Complications in Panniculectomy Patients

Nana Muazin July 23, 2026

For millions of individuals who have undergone significant weight loss, body contouring surgery—specifically panniculectomy—represents a vital, functional...

Read More Read more about Post-COVID Surgical Risks: New Study Links History of Infection to Elevated VTE Complications in Panniculectomy Patients

Restoring Sight: Science Corporation’s Prima System Marks a New Era for Geographic Atrophy Patients

• Treatment Innovations

Restoring Sight: Science Corporation’s Prima System Marks a New Era for Geographic Atrophy Patients

Nana Muazin July 23, 2026

In a landmark development for neuro-ophthalmology and bioelectronics, California-based Science Corporation has officially launched its Prima system...

Read More Read more about Restoring Sight: Science Corporation’s Prima System Marks a New Era for Geographic Atrophy Patients

Tariff Turbulence: How Proposed Levies on Generic Medicines Could Reshape the Pharmaceutical Landscape

• Chemotherapy and Targeted Therapy

Tariff Turbulence: How Proposed Levies on Generic Medicines Could Reshape the Pharmaceutical Landscape

Nana Muazin July 22, 2026

The Trump administration’s aggressive use of trade policy as a lever for domestic industrial policy has entered...

Read More Read more about Tariff Turbulence: How Proposed Levies on Generic Medicines Could Reshape the Pharmaceutical Landscape

Unveiling the Epigenetic Switch: How GATA6 Loss Fuels Colorectal Cancer’s Deadly Spread to the Liver

• Medical Research and Clinical Trials

Unveiling the Epigenetic Switch: How GATA6 Loss Fuels Colorectal Cancer’s Deadly Spread to the Liver

Nana Muazin July 22, 2026

New research from Weill Cornell Medicine and MIT identifies a critical epigenetic mechanism driving colorectal cancer metastasis,...

Read More Read more about Unveiling the Epigenetic Switch: How GATA6 Loss Fuels Colorectal Cancer’s Deadly Spread to the Liver

The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook

• Treatment Innovations

The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook

Nana Muazin July 21, 2026

The pharmaceutical landscape in the United States is undergoing a profound structural metamorphosis. As federal regulators and...

Read More Read more about The Economics of Constraint: How Most-Favored-Nation Pricing is Rewriting the Generic Drug Playbook